Change over period: —
NSE · GAUDIUMIVF
GAUDIUMIVF
-38.4% from the 52-week high · +37.8% above the low
Gaudium IVF & Women Health Ltd operates fertility and reproductive healthcare centers offering IVF and related treatments. The company provides services such as in vitro fertilization (IVF), IUI treatments, fertility preservation, gynecology consultations, and women’s health diagnostics. Its business model is based on specialized fertility clinics and patient-centric treatment programs. The company also offers advanced reproductive technologies and personalized fertility care. It primarily serves couples seeking infertility treatment and women’s healthcare services.
The short version. Return on equity was 16.1% in Mar 2026. Promoter holding was 71.29% in Sep 2026, up 0.00 points over 4 quarters.
1 · The price
How has the stock traded?
GAUDIUMIVF trades 38.4% below its 52-week high and 37.8% above its 52-week low.
2 · The business
Is it growing?
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | 37 | 19 | 30 | 25 |
| Net profit | 9 | 2 | 8 | 4 |
| Net margin % | 25.2 | 9.2 | 27.5 | 14.8 |
| EPS (₹) | 1.29 | 0.24 | 1.15 | 0.5 |
Annual
| FY2026 | |
|---|---|
| Revenue | 104 |
| Net profit | 24 |
| Net margin % | 23.4 |
| EPS (₹) | 3.36 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 16.1% in Mar 2026; debt to equity is 0.15.
Profitability · 1 years
Returns and margins
| Mar 2026 | |
|---|---|
| Return on equity % | 16.1 |
| Return on capital % | 23.1 |
| EBITDA margin % | 36.4 |
| Net margin % | 23.3 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Unchanged over 4 quarters.
Down 8.05 pts over 4 quarters.
Down 2.89 pts over 4 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|
| Promoter | 71.29 | 71.29 | 71.29 | 71.29 | 0.0 |
| FII | 9.24 | 6.7 | 3.02 | 1.19 | -8.05 |
| DII | 5.11 | 2.62 | 2.22 | 2.22 | -2.89 |
| Public | 14.36 | 19.39 | 23.47 | 25.29 | +10.93 |
Mutual fund holdings · Oct 2026
2 schemes hold this stock
2 the month before.
- Motilal Oswal BSE Healthcare ETF0.01% of NAV
- Bandhan BSE Healthcare Index Fund0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for GAUDIUMIVF are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about GAUDIUMIVF
What is the GAUDIUMIVF share price?
GAUDIUMIVF (GAUDIUMIVF) last closed at ₹98.76, up 1.4% on the day. Its 52-week range is ₹70.67 to ₹158.16.
What is the market cap of GAUDIUMIVF?
GAUDIUMIVF has a market capitalisation of about ₹710 crore. Its price-to-earnings ratio is 25.0.
How are GAUDIUMIVF's latest results?
Return on equity was 16.1% in Mar 2026. Promoter holding was 71.29% in Sep 2026, up 0.00 points over 4 quarters.
Who owns GAUDIUMIVF?
As of Sep 2026, shareholding was: Promoter 71.29%, FII 1.19%, DII 2.22%, Public 25.29%.
How many mutual funds hold GAUDIUMIVF?
2 mutual fund schemes held GAUDIUMIVF in October 2026. That compares with 2 the month before.
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.